Higher frequency of gene amplification in breast cancer patients who received adjuvant chemotherapy

Cancer

Volumn 77, Issue 1, 1996, Pages 107-112

  Lönn, Ulf ^a   Lönn, Sigrid ^a   Nilsson, Bo ^a   Stenkvist, Björn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

breast cancer; dihydrofolate reductase; gene amplification; recurrence; thymidylate synthase

Indexed keywords

CYCLOPHOSPHAMIDE; DIHYDROFOLATE REDUCTASE; FLUOROURACIL; METHOTREXATE; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; GENE AMPLIFICATION; HUMANS; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; TAMOXIFEN; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDYLATE SYNTHASE;

EID: 0030058722     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<107::AID-CNCR18>3.0.CO;2-9     Document Type: Article

References (16)

1. Nowell P. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
2. Fidler I. Critical factors in the biology of tumor cancer metastasis: 28th G.H.A. Clowes Memorial Award Lecture. Cancer Res 1990;50:6130-8.
3. Franzen S, Zajizek J. Aspiration biopsy in diagnosis of palpable lesions of the breast. Acta Radiol 1968;7:241-62.
4. Stenkvist B, Westman-Naeser S, Holmqvist J, Nordin B, Bengtsson E, Vegelius J, et al. Computerized nuclear morphometry as an objective method for characterizing human cancer cell populations. Cancer Res 1978;38:4688-97.
5. Lönn U, Lönn S, Nylen U, Stenkvist B. Appearance and detection of multiple copies of the mdr-1 gene in clinical samples of mammary carcinoma. Int J Cancer 1992;51:682-6.
6. Lönn U, Lönn S, Stenkvist B. Appearance of amplified thymidylate synthase or dihydrofolate reductase genes in Stage IV breast-cancer patients receiving endocrine treatment. Int J Cancer 1993;54:237-42.
7. Peto R, Pike M, Arrnitage P, Breslow N, Cox D, Howard S, et al. Design and analysis of randomized clinidal trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
8. Alt F, Kellens R, Bertino J, Schimke R. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variant of cultured murine cells. J Biol Chem 1978;253:1357-70.
9. Jenh C, Geyer P, Baskin F, Johnson L. Thymidylate synthetase gene amplification in fluorodeoxy-resistant mouse cell lines. Mol Pharmacol 1985;28:80-5.
10. Bonadonna G, Brusamolino E, Valagussa P. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405-10.
11. Bonadonna G, Rossi A, Valagussa P. Adjuvant CMF chemotherapy in operable breast cancer. Ten years later. World J Surg 1985;9:707-13.
12. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy I. Lancet 1992;339:1-15.
13. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of ealy breast cancer by hormonal, cytotoxic, or immune therapy II. Lancet 1992;339:71-85.
14. Brenner SE, Wahl GM, Von Hoff D. Double minute chromosomes and homogenously staining regions in tumours taken directly from patients versus in human tumour cells. Anti-Cancer Drugs 1991;2:11-25.
15. Kaufman RJ, Schimke R. Amplification and loss of dihydrofolate reductase genes in a chinese hamster ovary cell line. Mol Cell Biol 1981;1:1069-76.
16. Giulotto E, Knight C, Stark GR. Hamster cells with increased rates of DNA amplification, a new phenotype. Cell 1987;48:837-45.